Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2012, Vol. 10 ›› Issue (7): 766-776.doi: 10.3736/jcim20120707

• Original Clinical Research • Previous Articles     Next Articles

Chinese herbal medicine for patients with mild to moderate Alzheimer disease based on syndrome differentiation: A randomized controlled trial

Lu Yu1, Shui-miao Lin1(), Ru-qian Zhou1, Wei-jun Tang2, Pin-xian Huang3, Ying Dong3, Jian Wang1, Zhi-hua Yu1, Jiu-lin Chen1, LiWei4, San-li Xing1, Hui-juan Cao5, Hong-bin Zhao1   

  1. 1. Shanghai Geriatric Institute of Chinese Medicine, Shanghai 200031, China
    2. Department of Radiology, Huashan Hospital, Fudan University, Shanghai 200040, China
    3. Department of Preventive Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
    4. College of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
    5. Center for Traditional Chinese Medicine and Systems Biology, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
  • Received:2012-03-27 Accepted:2012-04-17 Online:2012-07-20 Published:2018-07-15
  • Contact: Lin Shui-miao E-mail:trastayl@hotmail.com

Background: Alzheimer disease (AD) is a chronic neurodegenerative disease that is characterized by its gradual progression. At present, the cause and mechanism of AD are yet unclear, and there is no effective therapy for treating it. With development of global aging, the prevalence rate of AD is increasing. The life quality of elderly people is affected severely by AD that is ultimately life-threatening. Recently, study on treating AD with traditional Chinese medicine (TCM) has deepened.
Objective: To explore the therapeutic effects of a syndrome differentiation-based TCM regime in treating patients with mild to moderate AD for improving cognition, and to evaluate the changes in brain function of AD patients observed by resting-state functional magnetic resonance imaging (fMRI) technique.DESIGN, SETTING, PARTICIPANTS AND INTERVENTIONS: Adopting the internationally recognized criteria developed by National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer’s Disease and Related Disorders Association, the clinical trial was conducted on 131 patients with mild to moderate AD from 5 communities and 7 social welfare institutions. Participants were accepted after informed consent was received, and laboratory tests and a head imaging study were conducted. The patients were randomly divided into Chinese medicine group (CMG) (66 cases) or Western medicine group (WMG) (65 cases). Patients in the CMG were treated monthly with Chinese medicine according to syndrome differentiation. Patients in the WMG were treated with donepezil at a dose of 5 mg once daily. The therapeutic course lasted 48 weeks.MAIN OUTCOME MEASURES: The scores of Mini-Mental State Examination (MMSE), Fuld Object-Memory Evaluation (FOM), Block Design (BD) and Digit Span (DS) were used to evaluate the cognitive function; resting-state fMRI was used for observing brain function. The questionnaires and fMRI were performed before and after treatments.
Results: The cognitive functions of the patients in the CMG and WMG were improved after treatment. MMSE score was improved significantly in both groups (P<0.05 or P<0.001). After 48 weeks of treatment, 70.91% patients in the CMG had an improved MMSE score and 20% got worse, however, 55.77% patients in the WMG were improved in MMSE score and 34.62% got worse. Scores of FOM denominator and BD increased significantly in both groups; scores of FOM numerator and DS were also increased in the CMG (P<0.05 or P<0.01). The results of fMRI suggested that both Chinese medicine and donepezil treatment improved the connectivity between posterior cingulated gyrus and specific areas in the brain. The influence range of Chinese medicine primarily impacted on the left parietal lobe, being less than the influence range of donepezil, which primarily affected both sides of frontal lobes.
Conclusion: TCM treatment based on syndrome differentiation is effective in improving cognitive function of patients with mild to moderate AD and increasing the brain function by increasing connectivity between posterior cingulated gyrus and specific areas in the brain.

Key words: drugs, Chinese herbal, Alzheimer disease, cognition disorders, resting-state functional magnetic resonance imaging, randomized controlled trial

Figure 1

Flow diagram of this randomized trial"

Table 1

MMSE scores of Chinese medicine group and donepezil group at different time points (x±s)"

Group Time point n MMSE score
Chinese medicine Before treatment 64 18.34±4.07
After 24-week treatment 56 20.57±5.67**
After 48-week treatment 55 20.71±5.70**
Donepezil Before treatment 62 17.48±4.50
After 24-week treatment 51 18.67±6.17*
After 48-week treatment 52 18.62±6.55*

Table 2

Scores of FOM, BD and DS of Chinese medicine group and donepezil group at different time points (x±s, scores)"

Group Time point n FOM numerator FOM denominator BD DS
Chinese medicine Before treatment 64 13.09±4.15 5.970±2.20 16.13±11.22 8.03±2.04
After 24-week treatment 56 14.16±4.24** 6.48±2.66* 16.66±11.18 8.43±2.05
After 48-week treatment 55 14.18±4.87** 6.58±2.51** 20.80±12.61** 8.71±2.27*
Donepezil Before treatment 62 13.11±3.84 5.50±2.10 14.44±10.87 8.37±2.42
After 24-week treatment 51 13.59±4.50 6.30±2.18** 15.33±11.99 8.41±2.84
After 48-week treatment 52 13.69±5.21 6.10±2.60* 16.94±13.96* 8.39±2.72

Table 3

Localization of the main cerebral regions with significant difference (P<0.01) in comparison of before and after treatment in Chinese medicine group"

Coordinate Cerebral region t value Number of voxels
X Y Z
–42 –60 –34 Left posterior cerbellar lobe 3.91 20
–6 –16 –10 Brain stem 3.66 115
–10 –48 66 Left parietal lobe 3.29 72
–34 –8 –34 Left hook back –3.08 15
38 –36 –34 Right anterior lobe of cerebellum –4.54 27
–18 –16 –34 Cerebellum –4.28 140
46 20 –34 Right temporal lobe –5.05 117
–26 44 –18 Left superior frontal gyrus –3.32 27
26 –80 –14 Right lateral occipital margin back –4.17 70
50 –32 30 Right inferior parietal lobule –4.13 651
46 –80 30 Right temporal lobe angular gyrus –3.16 17

Figure 2

Distribution of cerebral regions connected with posterior cingulated gyrus in Chinese medicine group The regions whose connectivity is improved after treatment are marked by red; the regions whose connectivity is declined after treatment are marked by blue. The images were the results tested by resting-state functional magnetic resonance imaging."

Table 4

Localization of the main cerebral regions with significant difference (P<0.01) in comparison of before and after treatment in donepezil group"

Coordinate Cerebral region t value Number of voxels
X Y Z
–42 –60 –6 Left temporal lobe 4.04 55
–2 –16 –6 Left brain stem 3.74 51
–26 –4 –6 Left lenticular nucleus 3.47 85
–14 –84 22 Left occipital lobe wedge back 3.01 44
10 –68 26 Right occipital lobe wedge back 3.23 19
–10 –28 70 Left frontal lobe 4.39 334
–6 28 18 Left anterior cingulated gyrus –3.63 45

Figure 3

Distribution of cerebral regions connected with posterior cingulated gyrus in donepezil group The regions whose connectivity is improved after treatment are marked by red; the regions whose connectivity is declined after treatment are marked by blue. The images were the results tested by resting-state functional magenetic resonance imaging."

Table 5

Localization of the main cerebral regions with significant difference (P<0.01) in comparison of the differences of before treatment and after treatment between two groups"

Coordinate Cerebral region t value Number of voxels
X Y Z
2 20 26 Anterior cingulated gyrus 3.42 18
–46 –48 –46 Left posterior lobe of cerebellum –3.74 44
34 12 –42 Right temporal lobe –3.60 55
–26 32 –22 Left inferior frontal gyrus –3.12 24
–10 –72 –6 Left occipital margin back –3.57 142
–54 4 2 Left superior temporal gyrus –3.74 27
46 –32 26 Right inferior parietal lobule –3.25 17
–14 52 26 Left superior frontal gyrus –3.02 44
–42 –80 34 Left parietal lobe wedge back –4.54 134
–2 –40 22 Left posterior cingulated gyrus –3.33 23
2 52 42 Right frontal gyrus –3.43 16

Figure 4

Distribution of cerebral regions connected with posterior cingulated gyrus The regions whose connectivity is improved after treatment evaluated by the difference between D-values of Chinese medicine group and donepezil group are marked by red; the regions whose connectivity is declined after treatment evaluated by the difference between D-values of Chinese medicine group and donepezil group are marked by blue. The images were the results tested by resting-state functional magenetic resonance imaging."

[1] Selkoe DJ . Alzheimer’s disease: genes, proteins, and therapy[J]. Physiol Rev, 2001,81(2):741-766
doi: 10.1152/physrev.2001.81.2.741 pmid: 11274343
[2] Niu YL, Zhang WJ . The study progress on etiology and pathogenesis of Alzheimer’s Disease[J]. Guo Wai Yi Xue Lao Nian Yi Xue Fen Ce, 2008,29(6):269-273
牛艳丽, 张维娟 . 阿尔茨海默病的病因及发病机理研究进展[J]. 国外医学(老年医学分册), 2008,29(6):269-273
[3] McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM . Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease[J]. Neurology, 1984,34(7):939-944
doi: 10.1212/WNL.34.7.939
[4] Folstein MF, Folstein SE , McHugh PR.“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician[J]. J Psychiatr Res, 1975,12(3):189-198
doi: 10.1016/0022-3956(75)90026-6
[5] Fuld PA . Fuld object-memory evaluation. Chicago: Stoelting. 1982.
[6] Wechsler D. WISC-R , Wechsler intelligence scale for children, revised. New York: Psychological Corporation. 1974.
[7] Gong YX.WAIS-RC , Manual for the Wechsler adult intelligence scale, China vision[M]. Changsha: Hunan Map Press, 1992: 48-55
龚耀先 . 中国修订韦氏成人智力量表手册[M]. 长沙: 湖南地图出版社, 1992: 48-55
[8] Herdon RM. Handbook of neurologic rating scales. 2nd ed.Translated by Jia JP, Chen H, Yan X[M]. Beijing: Chemical Industry Press, 2010: 196
Herdon RM. 神经疾病分级评分量表. 第2版.贾建平, 陈海, 闫欣译[M]. 北京: 化学工业出版社, 2010: 196
[9] Jin PH, Zhan SK. Medical statistics. Shanghai: Shanghai Medical University Press. 1993. Chinese.
金丕焕, 詹绍康 . 医用统计方法. 上海: 上海医科大学出版社. 1993.
[10] Lin SM, Yang BC, Lin SH . TCM study on progressive occult dementia[J]. Shanghai Zhong Yi Yao Za Zhi, 1994,( 10):9-11
林水淼, 杨柏灿, 林松华 . 对进行性隐匿型痴呆症的中医学研究[J]. 上海中医药杂志, 1994,( 10):9-11
[11] Lin SM, Zhou RQ, Wang J, Yu ZH . Comparative study of “Heart-Regulating Formula” and “Kidney-Tonifying Formula” in treating the cognition and daily life ability of Alzheimer’s disease[J]. Zhongguo Lao Nian Xue Za Zhi, 2002,22(6):434-436
林水淼, 周如倩, 王健, 郁志华 . 调心方、补肾方对Alzheimer病患者认知功能和日常生活能力作用的比较[J]. 中国老年学杂志, 2002,22(6):434-436
[12] Zhang MK, Yu XY . Epidemiology and prevention of senile dementia[J]. She Qu Yi Xue Za Zhi, 2005,3(11):37-38
张懋奎, 虞先滢 . 老年性痴呆的流行病学和预防对策[J]. 社区医学杂志, 2005,3(11):37-38
[13] Goedert M, Spillantini MG . A century of Alzheimer’s disease[J]. Science, 2006,314(5800):777-781
doi: 10.1126/science.1132814
[14] Heng XP, Sun HH . Zhang Fa-rong’s experience in treating dementia[J]. Sichuan Zhong Yi, 1997,15(2):4-5
衡先培, 孙鸿辉 . 张发荣论治老年期痴呆的经验[J]. 四川中医, 1997,15(2):4-5
[15] Yang DX, Lü LY . The relationship of dementia and blood stasis[J]. Liaoning Zhong Yi Za Zhi, 1991,( 8):37-38
颜德馨, 吕立言 . 老年性痴呆与淤血的关系[J]. 辽宁中医杂志, 1991,( 8):37-38
[16] Fu RJ, Wang YY, Ge MZ, Meng JM . Discussion on the treatment of dementia[J]. Zhong Yi Za Zhi, 1991,( 1):39-41
傅仁杰, 王永炎, 葛茂振, 孟家眉 . 老年期痴呆证治座谈[J]. 中医杂志, 1991,( 1):39-41
[17] Guo ZQ . Study on TCM diagnosis and treatment of senile dementia[J]. Zhong Yi Yao Yan Jiu, 1991,( 1):16-18
郭振球 . 老年期痴呆的证治学研究[J]. 中医药研究, 1991,( 1):16-18
[18] Delbeuck X , Van der Linden M, Collette F . Alzheimer’s disease as a disconnection syndrome? Neuropsychol Rev. 2003; 13(2):79-92.
doi: 10.1023/A:1023832305702 pmid: 12887040
[19] Greicius MD, Srivastava G, Reiss AL, Menon V . Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI[J]. Proc Natl Acad Sci U S A, 2004,101(13):4637-4642
doi: 10.1073/pnas.0308627101
[20] Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE . Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease[J]. Ann Neurol, 1997,42(1):85-94
doi: 10.1002/ana.410420114 pmid: 9225689
[21] Zhang HY, Wang SJ, Yang M, Ren LQ, Zhang ZJ, Teng GJ . Changes in posterior cingulated cortex functional connectivity of resting-state functional magnetic resonance imaging in mild Alzheimer’s disease[J]. Zhonghua Shen Jing Ke Za Zhi, 2008,41(7):471-475
张洪英, 王世杰, 杨明, 任利群, 张志珺, 滕皋军 . 静息状态功能磁共振成像观察轻度阿尔茨海默病后扣带回功能连通性的变化[J]. 中华神经科杂志, 2008,41(7):471-475
[22] Raichle ME , MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL .A default mode of brain function[J]. Proc Natl Acad Sci U S A, 2001,98(2):676-682
doi: 10.1073/pnas.98.2.676
[23] Wang L, Zang Y, He Y, Liang M, Zhang X, Tian L, Wu T, Jiang T, Li K . Changes in hippocampal connectivity in the early stages of Alzheimer’s disease: evidence from resting state fMRI[J]. Neuroimage, 2006,31(2):496-504
doi: 10.1016/j.neuroimage.2005.12.033
[24] He Y, Wang L, Zang Y, Tian L, Zhang X, Li K, Jiang T . Regional coherence changes in the early stages of Alzheimer’s disease: a combined structural and resting-state functional MRI study[J]. Neuroimage, 2007,35(2):488-500
doi: 10.1016/j.neuroimage.2006.11.042
[1] Chiung-Hui Huang, Mei-Ling Yeh, Fang-Pey Chen, Daphne Wu. Low-level laser acupuncture reduces postoperative pain and morphine consumption in older patients with total knee arthroplasty: A randomized placebo-controlled trial. Journal of Integrative Medicine, 2022, 20(4): 321-328.
[2] Maryam Azimi, Hanieh Niayesh, Mahboobeh Raeiszadeh, Sedigheh Khodabandeh-shahraki. Efficacy of the herbal formula of Foeniculum vulgare and Rosa damascena on elderly patients with functional constipation: A double-blind randomized controlled tria. Journal of Integrative Medicine, 2022, 20(3): 230-236.
[3] Ubiratan Cardinalli Adler, Maristela Schiabel Adler, Ana Elisa Madureira Padula, Livia Mitchiguian Hotta, Amarilysde Toledo Cesar, José Nelson Martins Diniz, Helen de Freitas Santos, Edson Zangiacomi Martinez. Homeopathy for COVID-19 in primary care: A randomized, double-blind, placebo-controlled trial (COVID-Simile study). Journal of Integrative Medicine, 2022, 20(3): 221-229.
[4] Xin Wang, Wen-juan Song, Yi Ruan, Bing-chu Li, Can Lü, Nian Huang, Fan-fu Fang, Wei Gu. Core muscle functional strength training for reducing the risk of low-back pain in military recruits: An open-label randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 145-152.
[5] Shu-yi Chen, Qun-wei Chen, Liu-mei Shou, Hong Pan, Shan-ming Ruan, Zhe-hao Liang, Qi-jin Shu. Stevens-Johnson syndrome/toxic epidermal necrolysis successfully treated with Chinese herbal medicine Pi-Yan-Ning: A case report. Journal of Integrative Medicine, 2021, 19(6): 555-560.
[6] Xin Yin, Shu-bin Cai, Lan-ting Tao, Lu-ming Chen, Zhong-de Zhang, Su-hong Xiao, Arthur Yin Fan, Xu Zou. Recovery of a patient with severe COVID-19 by acupuncture and Chinese herbal medicine adjuvant to standard care. Journal of Integrative Medicine, 2021, 19(5): 460-466.
[7] Meng-zhu Zhao, Chen Zhao, Shuang-shuang Tu, Xu-xu Wei, Hong-cai Shang. Evaluating the methodology of studies conducted during the global COVID-19 pandemic: A systematic review of randomized controlled trials. Journal of Integrative Medicine, 2021, 19(4): 317-326.
[8] Si-chun Gu, Jie Zhou, Qing Ye, Can-xing Yuan. Pingchan granule for depressive symptoms in Parkinson’s disease: A randomized, double-blind, placebo-controlled trial. Journal of Integrative Medicine, 2021, 19(2): 120-128.
[9] Jie Wu, Shu-wei Duan, Hong-tao Yang, Yue-yi Deng, Wei Li, Ya-ni He, Zhao-hui Ni, Yong-li Zhan, Shan Lin, Zhi-yong Guo, Jun Zhu, Jing-ai Fang, Xu-sheng Liu, Li-hua Wang, Rong Wang, Nian-song Wang, Xiao-hong Cheng, Li-qun He, Ping Luo, Shi-ren Sun s, Ji-feng Sun, Ai-ping Yin, Geng-ru Jiang, Hong-yu Chen, Wen-hu Liu, Hong-li Lin, Meng Liang, Lu Ma, Ming Chen, Li-qun Song, Jian Chen, Qing Zhu, Chang-ying Xing, Yun Li, Ji-ning Gao, Rong-shan Li, Ying Li, Hao Zhang, Ying Lu, Qiao-ling Zhou, Jun-zhou Fu, Qiang He, Guang-yan Cai, Xiang-mei Chen. Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial. Journal of Integrative Medicine, 2021, 19(2): 111-119.
[10] Xian Wang, Xuan Yin, Xiu-tian Guo, Yan Wang, Wen-qi Jin, Ai-jun Mao, Lixing Lao, Zhang-jin Zhang, Jie Zhang, Shi-fen Xu. Effects of the pestle needle therapy, a type of acupoint stimulation, on post-hemorrhoidectomy pain: A randomized controlled trial. Journal of Integrative Medicine, 2020, 18(6): 492-498.
[11] Qing-lan Wang, Yan-yan Tao, Hong-dong Xie, Cheng-hai Liu, Ping Liu. Fuzheng Huayu recipe, a traditional Chinese compound herbal medicine, attenuates renal interstitial fibrosis via targeting the miR-21/PTEN/AKT axis. Journal of Integrative Medicine, 2020, 18(6): 505-513.
[12] Ming-sheng Lyu, De-ying Li, Shao-zhong Zhou, Cheng-jun Ban, Jun Yan. Adult-onset Still's disease successfully treated with Chinese herbal medicine: A case report with 15-month follow-up. Journal of Integrative Medicine, 2020, 18(6): 530-534.
[13] Arthur Yin Fan, Sherman Gu, Sarah Faggert Alemi, Research Group for Evidence-based Chinese Medicine. Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis. Journal of Integrative Medicine, 2020, 18(5): 385-394.
[14] Bin Lan, Jin-wen Ge, Shao-wu Cheng, Xi-long Zheng, Jun Liao, Chao He, Zheng-qing Rao, Guo-zuo Wang. Extract of Naotaifang, a compound Chinese herbal medicine, protects neuron ferroptosis induced by acute cerebral ischemia in rats. Journal of Integrative Medicine, 2020, 18(4): 344-350.
[15] Sherman Gu, Arthur Yin Fan. Controversial conclusions from two randomized controlled trials for acupuncture's effects on polycystic ovary syndrome or in vitro fertilization support. Journal of Integrative Medicine, 2020, 18(2): 89-91.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239